Point72 Asset Management
PRCT icon

Point72 Asset Management’s Procept Biorobotics PRCT Stock Holding History

Point72 Asset Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,128,543
Closed -$28.2M – 4466
2026
Q1 		$28.2M Buy
+1,128,543
New +$31.8M 0.04% 637
2025
Q3 		– Sell
-64,152
Closed -$3.7M – 2610
2025
Q2 		$3.7M Buy
+64,152
New +$3.63M 0.01% 1071
2023
Q1 		– Sell
-108,294
Closed -$4.5M – 2484
2022
Q4 		$4.5M Buy
+108,294
New +$4.65M 0.02% 779
2021
Q4 		– Sell
-15,000
Closed -$572K – 1256
2021
Q3 		$572K Buy
+15,000
New +$576K ﹤0.01% 915

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Point72 Asset Management's PRCT Position: Q2 2026 in Review

Point72 Asset Management sold out of Procept Biorobotics (PRCT) in Q2 2026, closing a stake of 1,128,543 shares — an estimated $28.2M sold.

Point72 Asset Management first reported a position in PRCT in Q3 2021 and held it in 4 quarters. The position peaked at $28.2M in Q1 2026. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Point72 Asset Management reported no remaining Procept Biorobotics position as of Q2 2026 after selling out during the quarter.
  • Point72 Asset Management sold 1,128,543 Procept Biorobotics shares in Q2 2026, an estimated $28.2M.
  • Point72 Asset Management first reported a position in Procept Biorobotics in Q3 2021 and held it in 4 quarters.
  • Point72 Asset Management's Procept Biorobotics position peaked at $28.2M in Q1 2026.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.